Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0809-05

Nichols IRMA Intact PTH Assay, catalog No. 40-2171

Nichols Institute Diagnostics / initiated 2005-03-25 / Terminated / root cause: labeling and UDI

Nichols Institute Diagnostics began a recall of Nichols IRMA Intact PTH Assay, catalog No. 40-2171 on . The reason FDA records is "Firm noted a change in performance and therefore changed the labeled performance specifications in the Directional Insert portion of the labeling". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-0809-05
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Nichols Institute Diagnostics
Product
Nichols IRMA Intact PTH Assay, catalog No. 40-2171
Product code
CEW Radioimmunoassay, Parathyroid Hormone
Reason for recall
Firm noted a change in performance and therefore changed the labeled performance specifications in the Directional Insert portion of the labeling.
Root cause tag
labeling and UDI
FDA root cause
Other
Action
Firm sent customer notifications to firms on March 9 and 11, 2005 which were deemed not appropriate upon review by the FDA, firm agreed to resend notices approved by FDA on March 25, 2005 which requested that customers cease using the lots and destroy inventory for credit.
Quantity in commerce
Not divulged
Distribution
Nationwide, Canada, Greece, Italy, Sweden, Austria, Balgium, Korea, Spain, Grea Britian, Taiwan, Finland, Denmark, New Zealand, Israel
Product codes and lots
Lots 40-504553/4 released March 4, 2005 and kit lots 40-501687/8 released March 18, 2005